Health Condition 1: N813- Complete uterovaginal prolapse Health Condition 2: S720- Fracture of head and neck of femur Health Condition 3: S724- Fracture of lower end of femur Health Condition 4: S820- Fracture of patella Health Condition 5: S723- Fracture of shaft of femur Health Condition 6: S822- Fracture of shaft of tibia Health Condition 7: N433- Hydrocele, unspecified Health Condition 8: S722- Subtrochanteric fracture of femur Health Condition 9: K409- Unilateral inguinal hernia, without ob
Conditions
Interventions
Intervention1: Levobupivacaine Hydrochloride: 15 mL of 0.5% Levobupivacaine Hydrochloride (75 mg) single dose for Infra Umbilical Surgeries under Epidural Anaesthesia
Control Intervention1: Ropivacain
Sponsors
Dr Shreya Putta
Eligibility
Inclusion criteria
Inclusion criteria: Patients undergoing a given Infra umbilical surgeries giving consent to participate in study. Age between 18 to 60 years. ASA grade I and grade II
Exclusion criteria
Exclusion criteria: Patients not giving consent to participate in the study. ASA grade III and IV Patients with respiratory, cardiovascular, hepatic and renal diseases, obesity. Age below 60 years. Any bleeding disorder and patient on anticoagulants. Neurological and musculoskeletal disease. Local infection at the injection site. History of hypersensitivity or allergy to any drug
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Expected early onset of sensory & motor blockade & prolonged duration of analgesia with epidural ropivacaine 0.75%Timepoint: 24 hours | — |
Secondary
| Measure | Time frame |
|---|---|
| Expected stable haemodynamic profile & lesser side effects with epidural levobupivacaine 0.5%Timepoint: 24 hours | — |
Countries
India
Contacts
Public ContactDr S S Yadav
Gajra Raja Medical College, Gwalior
Outcome results
None listed